Status: Recruiting
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease
Dopason is a phase I, open-label, multicenter, single-arm clinical trial designed to evaluate the safety and feasibility of intraputaminal transplantation of human embryonic stem cell-derived dopaminergic progenitor cells (DopaCells) in patients with moderately severe Parkinson's disease.
Participants needed: 6
Trial details
Phase: Phase 1Age: 30-70Biological sex: AllType: InterventionalSponsor: Royan InstituteUpdated: Jun 18, 2026Locations: 3
Eligibility criteria
Age: 30-70 years [+12]
The abnormal function of immune system [+20]